Canadian Investment Regulatory Organization Trade Resumption - TCK.P Français
Company: Trillium Acquisition Corp.
TSX-Venture Symbol: TCK.P
All Issues: Yes
Resumption (ET): 9:30 AM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions
For further information about CIRO's trading halt policy, please see Trading Halts & Timely Disclosure at www.ciro.ca under the Markets tab. Please note that CIRO staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about CIRO, contact CIRO's Complaints & Inquiries team by submitting a Secure Form located on our contact page at www.ciro.ca or dialing 1-877-442-4322 (Option 1). For company-related enquiries, please contact the company directly.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
a few seconds ago
- Cision Canada
Canadian Investment Regulatory Organization Trading Halt - ARIS.WT.A Français
TORONTO, /CNW/ - The following issues have been halted by CIRO: Company: Aris Mining Corporation TSX Symbol: All Issues: No Reason: Pending Delisting Halt Time (ET): 12:00 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada. SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions For further information about CIRO's trading halt policy, please see Trading Halts & Timely Disclosure at under the Markets tab. Please note that CIRO staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about CIRO, contact CIRO's Complaints & Inquiries team by submitting a Secure Form located on our contact page at or dialing 1-877-442-4322 (Option 1). For company-related enquiries, please contact the company directly.
Cision Canada
a few seconds ago
- Cision Canada
DOLLARAMA TO REPORT SECOND QUARTER FISCAL 2026 RESULTS Français
MONTREAL, July 29, 2025 /CNW/ - Dollarama Inc. (TSX: DOL) ("Dollarama") will issue its financial results for the second quarter of Fiscal 2026, covering the period from May 5, 2025 to August 3, 2025, on Wednesday, August 27, 2025 at 7:00 a.m. (ET). Management will hold a conference call on the same day to discuss the results. Financial analysts are invited to ask questions by using the call link provided below. Other interested parties may participate in the call on a listen‑only basis via live audio webcast which will be available on Dollarama's website. About Dollarama Founded in 1992 and headquartered in Montréal, Quebec, Canada, Dollarama is a recognized Canadian value retailer offering a broad assortment of consumable products, general merchandise and seasonal items both in-store and online. With stores in all Canadian provinces and two territories, our 1,638 locations across Canada provide customers with compelling value in convenient locations, including metropolitan areas, mid-sized cities and small towns. Our quality merchandise is sold at select fixed price points up to $5.00. Dollarama also owns a 60.1% interest in Dollarcity, a growing Latin American value retailer. Dollarcity offers a broad assortment of consumable products, general merchandise and seasonal items at select, fixed price points up to US$4.00 (or the equivalent in local currency) in 644 conveniently located stores in Colombia, Guatemala, El Salvador and Peru.
Cision Canada
12 minutes ago
- Cision Canada
Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call
MISSISSAUGA, ON, July 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher" or the " Company") today announced that it will release its financial results for the second quarter of 2025 after the market close on Thursday, August 7, 2025. The Company will also hold a conference call on Friday, August 8, 2025 at 8:30am ET to discuss the results and corporate developments. CONFERENCE CALL DETAILS About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit SOURCE Cipher Pharmaceuticals Inc.
